Iodine Status and Characteristics of Papillary Thyroid Cancer
NCT06626581 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2024-10-04
Summary
The effect of iodine on papillary thyroid cancer has been controversial for many years. The investigators designed a cross-sectional study and aimed to explore the relationship between the serum and urine iodine levels and the clinical and molecular characteristics of papillary thyroid cancer.
Conditions
- Papillary Thyroid Carcinoma
Interventions
- DIETARY_SUPPLEMENT
-
Iodine excess
Iodine excess areas: water iodine ≥100μg/L; or urinary iodine concentration(median urinary iodine levels in children aged 8-10 years old) ≥300μg/L
- DIETARY_SUPPLEMENT
-
Iodine suitable
Iodine suitable areas: water iodine ≥40μg/L and ≤100μg/L; or urinary iodine concentration(median urinary iodine levels in children aged 8-10 years old) 100-199μg/L.
Sponsors & Collaborators
-
Shandong Provincial Hospital
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-01
- Primary Completion
- 2026-11-01
- Completion
- 2026-12-31
More Related Trials
-
Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer
NCT06362772 ·Status: COMPLETED
-
Effect of Thyrotropin Level on Iodine Uptake in Metastatic Differentiated Thyroid Cancer
NCT04880798 ·Status: UNKNOWN ·Phase: NA
-
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
NCT01413113 ·Status: COMPLETED ·Phase: PHASE1
-
Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
NCT04948437 ·Status: ACTIVE_NOT_RECRUITING
-
Study on the Relationship Between Iodine Nutrition and Thyroid Diseases in the Elderly
NCT05716191 ·Status: RECRUITING
-
Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma
NCT04683575 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer
NCT06627998 ·Status: RECRUITING
-
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
NCT05668962 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
NCT04868045 ·Status: WITHDRAWN ·Phase: PHASE1
-
Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition
NCT04619316 ·Status: UNKNOWN ·Phase: PHASE2
-
Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma
NCT05593744 ·Status: COMPLETED
-
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
NCT02393690 ·Status: COMPLETED ·Phase: PHASE2
-
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
NCT03624751 ·Status: ACTIVE_NOT_RECRUITING
-
CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer
NCT04495985 ·Status: ACTIVE_NOT_RECRUITING
-
Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
NCT00085293 ·Status: COMPLETED ·Phase: PHASE2
-
a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS
NCT06271044 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Iodine Supplementation in Graves' Hyperthyroidism
NCT06540469 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma
NCT00887107 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"
NCT06901908 ·Status: NOT_YET_RECRUITING
-
Testicular Function After Iodine 131 Therapy in Papillary Carcinoma Patients
NCT01150318 ·Status: COMPLETED ·Phase: NA
-
the Microbiota Are Associated With Iodine-131 Therapy and Hypothyroidism
NCT03574051 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
NCT06268600 ·Status: RECRUITING ·Phase: NA
-
The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter
NCT01384786 ·Status: COMPLETED
-
An Iodine Balance Study to Investigate the Recommended Iodine Intake in an Elderly Population
NCT06218043 ·Status: RECRUITING ·Phase: NA
-
Hyperthyroid Follow-Up Study
NCT02989103 ·Status: COMPLETED